Aristo Bio-Tech and Lifescience Limited has submitted the compliance certificate for its Structured Digital Database (SDD) for the financial year ended March 31, 2026, to the National Stock Exchange of India Limited. The certification confirms that the company successfully captured all four unpublished price sensitive information (UPSI) events required during the period, ensuring adherence to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

The certificate, issued by M/s SCS & Co. LLP, Practicing Company Secretaries, validates the internal controls and maintenance of the digital database. The auditors confirmed that the system is non-tamperable and possesses the capability to maintain records for eight years. The verification process included physical checks of the SDD and confirmations received from the company's management via email.

Key Compliance Details

The certification process covered several critical aspects of the SDD framework. The auditors relied on management representations and public domain information to verify the classification of information as UPSI. The engagement focused specifically on checking compliance with the requirements for maintaining the database and capturing the nature of UPSI disseminated during FY26.

Scope and Limitations

M/s SCS & Co. LLP noted that the maintenance of the SDD remains the responsibility of the company's management. The certification is limited to the extent of compliance required by NSE Circular No. NSE/CML/2024/31 dated October 18, 2024, and the relevant PIT Regulations. The firm performed verification on a test basis to provide reasonable assurance regarding the sanctity of the processes and the correctness of the records.